This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Daewoong Pharmaceutical Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Min-June Shim: Innovator in Pharmaceutical Composition
Introduction
Min-June Shim is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for medical applications. His work focuses on creating effective treatments for autoimmune diseases and cancers.
Latest Patents
Min-June Shim holds a patent for "4-aminopyrazolo[3,4-d]pyrimidinylazabicyclo derivatives and pharmaceutical composition comprising the same." This invention relates to derivatives that exhibit BTK inhibitory activity with high selectivity for BTK over ITK. The pharmaceutical compositions developed from these derivatives are promising for the prevention and treatment of various autoimmune diseases and cancers.
Career Highlights
Shim is currently associated with Daewoong Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His innovative approach has positioned him as a key player in the pharmaceutical industry, contributing to the creation of effective therapeutic solutions.
Collaborations
Some of his notable coworkers include Youn-Jung Yoon and Jung-eun Park, who collaborate with him on various projects within the company.
Conclusion
Min-June Shim's work exemplifies the impact of innovation in the pharmaceutical sector. His contributions are paving the way for new treatments that can significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile